NIAID Banner Logo Image

Other Viruses Citation List:

January 6 - January 19, 2012

Herpes simplex virus 1

1. Design of Xanthone propionate Photolabile Protecting Group Releasing Acyclovir for the Treatment of Ocular Herpes Simplex Virus. Blake, J.A., B. Bareiss, L. Jimenez, M. Griffith, and J.C. Scaiano, Photochemical & photobiological sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology, 2012. [Epub ahead of print]; PMID[22222893].

[Pubmed]. OV_0106-011912.

Hepatitis C virus

2. A Novel Class of Highly Potent Irreversible Hepatitis C Virus (HCV) NS5B Polymerase Inhibitors. Chen, K.X., C.A. Lesburg, B. Vibulbhan, W. Yang, T.Y. Chan, S. Venkatraman, F. Velazquez, Q. Zeng, F. Bennett, G.N. Anilkumar, J. Duca, Y. Jiang, P. Pinto, L. Wang, Y. Huang, O. Selyutin, S. Gavalas, H. Pu, S. Agrawal, B. Feld, H.C. Huang, C. Li, K.C. Cheng, N.Y. Shih, J.A. Kozlowski, S.B. Rosenblum, and F.G. Njoroge, Journal of medicinal chemistry, 2012. [Epub ahead of print]; PMID[22247956].

[Pubmed].

OV_0106-011912.

3. Discovery of GS-9256: A Novel Phosphinic acid Derived Inhibitor of the Hepatitis C Virus NS3/4A Protease with Potent Clinical Activity. Sheng, X.C., A. Casarez, R. Cai, M.O. Clarke, X. Chen, A. Cho, W.E.t. Delaney, E. Doerffler, M. Ji, M. Mertzman, R. Pakdaman, H.J. Pyun, T. Rowe, Q. Wu, J. Xu, and C.U. Kim, Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[22244938].

[Pubmed]. OV_0106-011912.

4. Suppression of Hepatitis C Virus by the Flavonoid Quercetin is Mediated by Inhibition of NS3 protease Activity. Bachmetov, L., M. Gal-Tanamy, A. Shapira, M. Vorobeychik, T. Giterman-Galam, P. Sathiyamoorthy, A. Golan-Goldhirsh, I. Benhar, R. Tur-Kaspa, and R. Zemel, Journal of Viral Hepatitis, 2012. 19(2): p. e81-e88; PMID[22239530].

[Pubmed]. OV_0106-011912.

5. Synthesis of New 4,5-Dihydrofuranoindoles and Their Evaluation as HCV NS5B Polymerase Inhibitors. Velazquez, F., S. Venkatraman, C.A. Lesburg, J. Duca, S.B. Rosenblum, J.A. Kozlowski, and F.G. Njoroge, Organic letters, 2012. [Epub ahead of print]; PMID[22220815].

[Pubmed]. OV_0106-011912.

6. Tiling Genomes of Pathogenic Viruses Identifies Potent Antiviral shRNAs and Reveals a Role for Secondary Structure in shRNA Efficacy. Tan, X., Z.J. Lu, G. Gao, Q. Xu, L. Hu, C. Fellmann, M.Z. Li, H. Qu, S.W. Lowe, G.J. Hannon, and S.J. Elledge, Proceedings of the National Academy of Sciences of the United States of America, 2012. [Epub ahead of print]; PMID[22219365].

[Pubmed]. OV_0106-011912.

Citations from the ISI Web of Knowledge Listings for O.V.

7. The Green Tea Polyphenol, Epigallocatechin-3-gallate, Inhibits Hepatitis C Virus Entry. Ciesek, S., T. von Hahn, C.C. Colpitts, L.M. Schang, M. Friesland, J. Steinmann, M.P. Manns, M. Ott, H. Wedemeyer, P. Meuleman, T. Pietschmann, and E. Steinmann, Hepatology, 2011. 54(6): p. 1947-1955; ISI[000297974900007].

[WOS]. OV_0106-011912.

8. Novel anti-HCV Therapy: Single shRNA Targeting both Strands of HCV. Lisowski, L., M. Elazar, K. Chu, J.S. Glenn, and M.A. Kay, Journal of Gene Medicine, 2011. 13(7-8): p. 418-419; ISI[000297950900020].

[WOS]. OV_0106-011912.

9. Effects of Hypolipidemic Agent Nordihydroguaiaretic acid on Lipid Droplets and Hepatitis C Virus. Syed, G.H. and A. Siddiqui, Hepatology, 2011. 54(6): p. 1936-1946; ISI[000297974900006].

[WOS]. OV_0106-011912.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2022